Oral Piracetam vs Betahistine in Outpatient Management of Peripheral Vertigo; a Randomized Clinical Trial

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

ARHAMI DOLATABADI ALI; Larimi Seyedeh Roghieh; SAFAIE ARASH

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Archives of Academic Emergency Medicine Year:2019 | Volume:7 | Issue:1 Page(s): 0-0

Download Full-Text

View:

237

Download:

147

Cites:

Information Journal Paper

Title

Oral Piracetam vs Betahistine in Outpatient Management of Peripheral Vertigo; a Randomized Clinical Trial

Author(s)

ARHAMI DOLATABADI ALI | Larimi Seyedeh Roghieh | SAFAIE ARASH | Issue Writer Certificate

Keywords

Vertigo

piracetam

betahistine

emergencymedicine

treatment outcome

Abstract

Introduction: Although Vertigo is a common complaint in patients presenting to the emergency department (ED), its ideal treatment is still under debate. This study was conducted to compare oral betahistine and oral piracetam in management of outpatients with peripheral Vertigo. Methods: This was a randomized clinical trial performed on patients who were presented to the EDs of 4 teaching hospitals, with complaint of true Vertigo. Patients were randomly allocated to either betahistine or piracetam group and their 7-day outcomes were compared. Results: 100 cases with the mean age of 54. 72 § 14. 09 years were randomly allocated to either group (62. 0%female). The two groups were similar regarding age, sex, and intensity of symptom at the time of presenting to the ED. Twelve (24%) patients in piracetam group and 6 (12%) patients in betahistine group experienced adverse events (odds ratio: 2. 32, CI 95%: 0. 79-6. 76; p = 0. 125). There were 3 (6%) patients in each group that experienced a recurrence of their symptoms and 2 (4%) patients in each group saw another physician for Vertigo. Conclusion: Oral piracetam is a potentially proper treatment for management of peripheral Vertigo and there are few adverse effects associated with it.

Cites

No record.

References

No record.

Cite

APA: Copy

ARHAMI DOLATABADI, ALI, Larimi, Seyedeh Roghieh, & SAFAIE, ARASH. (2019). Oral Piracetam vs Betahistine in Outpatient Management of Peripheral Vertigo; a Randomized Clinical Trial. ARCHIVES OF ACADEMIC EMERGENCY MEDICINE (EMERGENCY), 7(1), 0-0. SID. https://sid.ir/paper/339820/en

Vancouver: Copy

ARHAMI DOLATABADI ALI, Larimi Seyedeh Roghieh, SAFAIE ARASH. Oral Piracetam vs Betahistine in Outpatient Management of Peripheral Vertigo; a Randomized Clinical Trial. ARCHIVES OF ACADEMIC EMERGENCY MEDICINE (EMERGENCY)[Internet]. 2019;7(1):0-0. Available from: https://sid.ir/paper/339820/en

IEEE: Copy

ALI ARHAMI DOLATABADI, Seyedeh Roghieh Larimi, and ARASH SAFAIE, “Oral Piracetam vs Betahistine in Outpatient Management of Peripheral Vertigo; a Randomized Clinical Trial,” ARCHIVES OF ACADEMIC EMERGENCY MEDICINE (EMERGENCY), vol. 7, no. 1, pp. 0–0, 2019, [Online]. Available: https://sid.ir/paper/339820/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops